Your browser doesn't support javascript.
loading
Economic Burden of Healthcare Services on Cancer Survivors in Bangladesh.
Shahjalal, Md; Dahal, Padam Kanta; Mosharaf, Md Parvez; Alam, Mohammad Morshad; Hawlader, Mohammad Delwer Hossain; Mahumud, Rashidul Alam.
Afiliación
  • Shahjalal M; Department of Public Health, North South University, Dhaka, Bangladesh.
  • Dahal PK; Research Rats, Dhaka, Bangladesh.
  • Mosharaf MP; School of Health, Medical and Applied Sciences, Central Queensland University, Sydney, New South Wales, Australia.
  • Alam MM; School of Business and Centre for Health Research, University of Southern Queensland, Toowoomba, Queensland, Australia.
  • Hawlader MDH; Department of Public Health, North South University, Dhaka, Bangladesh.
  • Mahumud RA; Research Rats, Dhaka, Bangladesh.
Cancer Rep (Hoboken) ; 7(8): e2144, 2024 Aug.
Article en En | MEDLINE | ID: mdl-39118451
ABSTRACT

BACKGROUND:

Cancer is a critical public health issue that imposes a considerable economic burden, especially in low-resource countries. In Bangladesh, there has been a noticeable lack of research focusing on the economic burden associated with cancer.

AIMS:

This study aimed to examine the economic burden of cancer care and the contributing factors.

METHODS:

This cross-sectional study included 623 cancer patients. Data were collected between January and May 2022. The magnitude of the economic burden (no burden to extreme burden) was the outcome variable. A logistic regression model was performed to determine the associated factors of the economic burden of cancer.

RESULTS:

Overall, 34% of cancer survivors experienced extreme economic burden due to treatment costs. Patients with prostate (relative risk ratio, RRR = 23.24; 95% confidence interval, CI 1.97, 273.70), bone (RRR = 5.85; 95% CI 1.10, 31.04), and liver cancer (RRR = 4.94; 95% CI 1.29, 18.9) reported significantly higher extreme economic burden compared to patients with other cancers. The economic burden was significantly higher for patients diagnosed with Stage III (RRR = 38.69; 95% CI 6.17, 242.72) and Stage IV (RRR = 24.74; 95% CI 3.22, 190.11) compared to Stage 0. Patients from low-income households suffered from nine times more extreme burden (RRR = 8.85; 95% CI 4.05, 19.36) compared with those from high-income households.

CONCLUSION:

Our study found a disproportionately high economic burden among patients with cancer, across disease sites, stages, and income quintiles. The burden was significantly higher among patients with prostate, bone, and liver cancer, and those diagnosed with advanced stage. The findings underscore the importance of early cancer detection before metastasis which may lead to more efficient treatment, avoid disease progression, lower disease management costs, and better health outcomes. Patients from low-income households experience an extreme economic burden due to cancer, highlighting the need for affordable healthcare services, financial support, and healthcare subsidies.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Costo de Enfermedad / Supervivientes de Cáncer / Neoplasias Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Cancer Rep (Hoboken) Año: 2024 Tipo del documento: Article País de afiliación: Bangladesh Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Costo de Enfermedad / Supervivientes de Cáncer / Neoplasias Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Cancer Rep (Hoboken) Año: 2024 Tipo del documento: Article País de afiliación: Bangladesh Pais de publicación: Estados Unidos